Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Subcutaneous DNK-FLU in Healthy Japanese Adults
jRCT2080222415Phase 2
- Sponsor
- Denka
- Start
- Mar 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of DNK-FLU in influenza, sponsored by Denka.
02
Drugs
DNK-FLU
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080222415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222415.